Abiopharma

🔍 RICHMOND DONALD P. II (Executive)

Company: AEHR TEST SYSTEMS (AEHR)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 2,120 shares of Common Stock at $6.6725 per share (Direct)
  Date: 2026-04-01 | Code: J | equity_swap_involved: false | shares_owned_after: 215,337.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 341 shares of Common Stock at $44.32 per share (Direct)
  Date: 2026-04-02 | Code: F | equity_swap_involved: false | shares_owned_after: 214,996.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities.
• F2: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.
• F3: The amount reported includes shares subject to unvested restricted stock units.